Fredin H, Lindblad B, Jaroszewski H, Bergqvist D
Acta Chir Scand. 1985;151(8):681-4.
The efficacy of dextran 70 with or without dihydroergotamine as prophylaxis against deep venous thrombosis (DVT) was tested prospectively in a randomized series of 65 patients with fracture of the hip. Diagnostic evaluation was made with bilateral ascending phlebography on postoperative day 7. In the dextran 70 group, 5 of the 27 phlebographically studied patients had DVT, an incidence not significantly different from the 10 DVT among 28 patients given dextran 70 + dihydroergotamine. Bleeding complications showed no intergroup difference. The study did not confirm a beneficial effect of dextran 70 in combination with dihydroergotamine as compared with dextran alone in regard to thrombotic complications after surgery for hip fracture.
在一项针对65例髋部骨折患者的前瞻性随机研究中,测试了右旋糖酐70单独或联合双氢麦角胺预防深静脉血栓形成(DVT)的疗效。术后第7天采用双侧上行静脉造影进行诊断评估。在右旋糖酐70组中,27例接受静脉造影检查的患者中有5例发生DVT,这一发生率与28例接受右旋糖酐70 + 双氢麦角胺治疗的患者中10例发生DVT的发生率相比,无显著差异。出血并发症在组间无差异。该研究未证实与单独使用右旋糖酐相比,右旋糖酐70联合双氢麦角胺在髋部骨折手术后的血栓形成并发症方面具有有益效果。